BEUDAMED
    FDA Adverse Event Malfunction Summary report: N

    BINAXNOW COVID-19 AG SELF TEST 2CT

    MDR report key: 17085956 · Received June 8, 2023

    Report

    Report Number
    1221359-2023-01199
    Event Type
    Malfunction
    Date Received
    June 8, 2023
    Date of Event
    May 30, 2023
    Report Date
    June 20, 2023
    Manufacturer
    ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
    Product Code
    QKP
    UDI-DI
    00811877011408
    PMA / PMN Number
    EUA210264
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    US
    Reporter Occupation
    003

    Narratives

    Additional Manufacturer Narrative · 0

    TESTING WAS PERFORMED AT ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ON RETAINED KIT LOT 223487 WITH INTERNAL POSITIVE QUALITY CONTROL SAMPLES AND NEGATIVE QUALITY CONTROL SWABS. ALL TEST RESULTS WERE VALID AND PERFORMED AS EXPECTED. ADDITIONALLY, THE MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING WAS REVIEWED FOR TEST KIT PART NUMBER 195-160 / LOT 223487, TEST BASE PART NUMBER 195-430WL / LOT 219837. THE LOT MET THE REQUIRED RELEASE SPECIFICATIONS. A REVIEW OF THE COMPLAINTS REPORTED AS FALSE NEGATIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) RELATED TO KIT LOT 223487 SHOWED THAT THE COMPLAINT RATE IS (B)(4). IN CONCLUSION, ABBOTT DIAGNOSTICS SCARBOROUGH WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE; HOWEVER, IT COULD POSSIBLY BE RELATED TO ISSUES INCLUDING THE SELF-TEST USER PERFORMANCE, INTERPRETATION OF THE RESULT, OR THE SPECIFIC PATIENT SAMPLE. H3 OTHER TEXT : SINGLE USE, DEVICE DISCARDED.

    Additional Manufacturer Narrative · 0

    THE REMAINDER OF THE INVESTIGATION REMAINS IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION. H3 OTHER TEXT : SINGLE USE, DEVICE DISCARDED.

    Description of Event or Problem · 0

    THE CUSTOMER REPORTED A FALSE NEGATIVE RESULT WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST PERFORMED ON (B)(6) 2023 ON A NASAL SAMPLE. INITIAL TESTING WAS PERFORMED USING AN UNKNOWN BRAND OF RAPID ANTIGEN TEST ON (B)(6) 2023 WHICH PRODUCED POSITIVE RESULTS. REPEAT TESTING WAS NOT PERFORMED. NO PCR WAS REPORTED TO HAVE BEEN PERFORMED. THE CONSUMER CONFIRMED THERE WAS NO DEATH OR SERIOUS INJURY. NO ADDITIONAL PATIENT INFORMATION, INCLUDING TREATMENT, WAS PROVIDED.

    Description of Event or Problem · 0

    THE CUSTOMER REPORTED A FALSE NEGATIVE RESULT WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST PERFORMED ON (B)(6) 2023 ON A NASAL SAMPLE. INITIAL TESTING WAS PERFORMED USING AN UNKNOWN BRAND OF RAPID ANTIGEN TEST ON (B)(6) 2023 THROUGH (B)(6) 2023 WHICH PRODUCED POSITIVE RESULTS. REPEAT TESTING WAS NOT PERFORMED. NO PCR WAS REPORTED TO HAVE BEEN PERFORMED. THE CONSUMER CONFIRMED THERE WAS NO DEATH OR SERIOUS INJURY. NO ADDITIONAL PATIENT INFORMATION, INCLUDING TREATMENT, WAS PROVIDED.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1274776 BINAXNOW COVID-19 AG SELF TEST 2CT CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. QKP ABBOTT DIAGNOSTICS SCARBOROUGH, INC. 223487 00811877011408

    Patients

    Seq Age Sex Outcome Treatment
    1 65 YR Male